Exact Mass: 246.1844
Exact Mass Matches: 246.1844
Found 441 metabolites which its exact mass value is equals to given mass value 246.1844,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
L-Tryptophan betaine
Hypaphorine is an amino acid betaine obtaine by exhaustive methylation of the alpha-amino group of L-tryptophan with concomitant deprotonation of the carboxy group. It has a role as a plant metabolite, a xenobiotic and a fungal metabolite. It is an amino-acid betaine, a L-tryptophan derivative and an indole alkaloid. Hypaphorine is a natural product found in Erythrina suberosa, Erythrina subumbrans, and other organisms with data available. Lenticin or hypaphorine is a compound found in lentil extracts. It can also be detected in blood after an individual has consumed lentils and may therefore serve as a food biomarker. Lenticin is an indole alkaloid that is essentially an N-methylated form of tryptophan. It is known to be a sleep-inducing compound (PMID: 18571406). In plants it is an agonist of the plant hormone indole acetic acid. An amino acid betaine obtaine by exhaustive methylation of the alpha-amino group of L-tryptophan with concomitant deprotonation of the carboxy group. (+)-Hypaphorine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=487-58-1 (retrieved 2024-07-01) (CAS RN: 487-58-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Hypaphorine is an indole alkaloid isolated from Caragana korshinskii, and with neurological and glucose-lowering effects in rodents[1]. Hypaphorine is an indole alkaloid isolated from Caragana korshinskii, and with neurological and glucose-lowering effects in rodents[1].
Mepivacaine
A local anesthetic that is chemically related to bupivacaine but pharmacologically related to lidocaine. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168) D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3126
Milnacipran
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D049990 - Membrane Transport Modulators
4-[(2E)-3,7-dimethylocta-2,6-dienyl]benzene-1,3-diol
Milnacipran
Milnacipran is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class. Milnacipran has been approved and sold in Austria since September 1998 under the brand name Ixel. Cypress Bioscience bought the exclusive rights for approval and marketing of the drug for any purpose in the US and Canada in 2003 from the manufacturer Pierre Fabre; the approval procedure in both countries is ongoing. D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D049990 - Membrane Transport Modulators
Avocadienofuran
Avocadienofuran is found in fruits. Avocadienofuran is a constituent of Persea americana (avocado)
Avocadynofuran
Avocadynofuran is found in avocado. Avocadynofuran is a constituent of Persea americana (avocado) Constituent of Persea americana (avocado). Avocadynofuran is found in avocado and fruits.
Ginsenoyne J
Ginsenoyne J is found in tea. Ginsenoyne J is a constituent of the roots of Panax ginseng. Constituent of the roots of Panax ginseng. Ginsenoyne J is found in tea.
Isoavocadienofuran
Isoavocadienofuran is found in avocado. Isoavocadienofuran is a component of Avocatin X, a constituent of the seeds of Persea gratissima (avocado Component of Avocatin X, a constituent of the seeds of Persea gratissima (avocado). Isoavocadienofuran is found in avocado and fruits.
MG(10:0/0:0/0:0)
MG(10:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(10:0/0:0/0:0) is made up of one decanoyl(R1).
3-Hydroxydodecanedioic acid
3-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders. Peroxisomal biogenesis disorders (PBDs) are characterized by generalized peroxisomal dysfunction due to defective assembly of the organelle and include the Zellweger, neonatal adrenoleukodystrophy and infantile Refsum phenotypes (PMID 10896310) [HMDB] 3-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders. Peroxisomal biogenesis disorders (PBDs) are characterized by generalized peroxisomal dysfunction due to defective assembly of the organelle and include the Zellweger, neonatal adrenoleukodystrophy and infantile Refsum phenotypes (PMID 10896310).
Valerylcarnitine
Valerylcarnitine is an acylcarnitine. More specifically, it is an valeric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Valerylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine valerylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular valerylcarnitine is elevated in the blood or plasma of individuals with exudative age-related macular degeneration (PMID: 32120889), type 2 Diabetes Mellitus (PMID: 31782507, PMID: 20111019), obesity (PMID: 20111019), acute cerebral infarction (PMID: 29265114), diastolic heart failure (PMID: 26010610), systolic heart failure (PMID: 26010610). It is also decreased in the blood or plasma of individuals with pregnancy (PMID: 24704061 - in serum of pregnant women with fetus with CHD). Valerylcarnitine can also be found cerebrospinal fluid (CSF), and urine. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Dibutyl malate
Dibutyl malate is found in fruits. Dibutyl malate is isolated from tamarind fruits (Tamarindus indica
8,8-Diethoxy-2,6-dimethyl-2-octanol
8,8-Diethoxy-2,6-dimethyl-2-octanol is used in citrus fruit flavourin It is used in citrus fruit flavouring
alpha-Amylcinnamyl acetate
alpha-Amylcinnamyl acetate is a flavouring ingredien Flavouring ingredient
Heptyl cinnamate
Heptyl cinnamate is a flavouring ingredient. Flavouring ingredient
(S)-3-Methylthiohexyl hexanoate
(S)-3-Methylthiohexyl hexanoate is found in fruits. (S)-3-Methylthiohexyl hexanoate is a constituent of volatile oil of yellow passion fruit (Passiflora edulis f. flavicarpa). Constituent of volatile oil of yellow passion fruit (Passiflora edulis f. flavicarpa). (S)-3-Methylthiohexyl hexanoate is found in fruits.
Demethoxyshogaol
Demethoxyshogaol is found in herbs and spices. Demethoxyshogaol is a constituent of ginger (Zingiber officinale). Constituent of ginger (Zingiber officinale). Demethoxyshogaol is found in herbs and spices.
MG(0:0/10:0/0:0)
MG(0:0/10:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/10:0/0:0) is made up of one decanoyl(R2).
Levomilnacipran
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D002491 - Central Nervous System Agents > D000700 - Analgesics D049990 - Membrane Transport Modulators
Nefiracetam
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal systems enhancer for Ro 5-4864-induced convulsions. Target: GABA Receptor Nefiracetam induces a short-term depression of ACh-evoked currents at submicromolar concentrations (0.01-0.1 μM) and a long-term enhancement of the currents at micromolar concentrations (1-10 μM). Nefiracetam interacts with PKA and PKC pathways, which may explain a cellular mechanism for the action of cognition-enhancing agents. Lower (submicromolar) concentrations of the nootropic Nefiracetam reduces ACh-evoked currents to 30\% (0.01 μM) and 38\% (0.1 μM) of control after a 10-minute treatment [1]. Nefiracetam administered orally inhibits Ro 5-4864-induced convulsions in EL mice. Nefiracetam also efficiently inhibits Ro 5-4864-induced convulsions in DDY mice at doses higher than 10 mg/kg [2]. Nefiracetam administered daily 1 hour before each training session facilitates the acquisition process of the avoidance response [3].
Parsalmide
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Piquindone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
N,1-Dimethyl-N-(4-methylphenyl)piperidine-2-carboxamide
1ST40360
Sophocarpine is a natural product found in Daphniphyllum oldhamii, Sophora viciifolia, and other organisms with data available. Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1]. Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1]. Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1].
Undecylthioacetic acid
CONFIDENCE standard compound; INTERNAL_ID 154; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5206; ORIGINAL_PRECURSOR_SCAN_NO 5201 CONFIDENCE standard compound; INTERNAL_ID 154; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5209; ORIGINAL_PRECURSOR_SCAN_NO 5205 CONFIDENCE standard compound; INTERNAL_ID 154; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5186; ORIGINAL_PRECURSOR_SCAN_NO 5184 CONFIDENCE standard compound; INTERNAL_ID 154; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5187; ORIGINAL_PRECURSOR_SCAN_NO 5185 CONFIDENCE standard compound; INTERNAL_ID 154; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5197; ORIGINAL_PRECURSOR_SCAN_NO 5196
(E,E,E)-1,7-diphenyl-1,3,5-heptatriene|1,7-diphenylhepta-1,3,5-triene
Albertin|ent-7,11-didehydro-matridin-15-one|Leontalbinin
4-allyl-3-methyl-1,2,3,4,5,6,11,11a-octahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-10-one|N-Methyl-albin|N-Methylalbin
(7R)-(14at)-3,4,7,9,10,11,13,14,14a-decahydro-2H-7r,14c-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-6-one|5,6-Dehydro-17-oxo-spartein|5,6-didehydro-17-oxosparteine|Delta5(6)-Dehydro-17-oxo-spartein|Delta5-Dehydro-17-oxo-spartein
(Z)-9-Heptadecene-4,6-diyne-1-ol|cis-Heptadecen-(9)-diin-(4,6)-ol-(1)|Heptadec-9c-en-4,6-diin-1-ol|heptadec-9c-ene-4,6-diyn-1-ol|Heptadecen-(9c)-diin-(4,6)-ol-(1)
(Z)-9-Heptadecene-4,6-diyne-8-ol|heptadec-9c-ene-4,6-diyn-8-ol|Heptadecen-(9c)-diin-(4,6)-ol-(8)
(E)-14,15,16-trinorlabda-8(17),11-dien-13-al|14,15,16-Trinor-8(17),11-labdadien-13-al
2-methoxyfuranodiene|8??-Methoxyfuranodiene|methoxyfuranodiene
16-Heptadecene-4,6-diyne-8-ol|heptadec-16-ene-4,6-diyn-8-ol|Heptadecen-(16)-diin-(4,6)-ol-(8)
(S)-panaxjapyne A|(Z)-heptadec-9-ene-4,6-diyn-(3S)-ol|panaxjapyne A
6alpha,15beta-epoxyeremophila-7(11)-en-8alpha,12-olide
(1R*,2R*,4R*,7R*,12R*)-8-methylenetetracyclo[5.3.2.0(2,4).0(4,12)]dodec-2-ylacetic acid methyl ester|chinopine B
(-)-(R)-(ar)-curcumen-12-oic acid methyl ester|(R)-Methyl curcumenoate
4-hydroxy-15-hexadecene-5,7-diynyl-2-one|homomontiporyne J
Nefiracetam
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal systems enhancer for Ro 5-4864-induced convulsions. Target: GABA Receptor Nefiracetam induces a short-term depression of ACh-evoked currents at submicromolar concentrations (0.01-0.1 μM) and a long-term enhancement of the currents at micromolar concentrations (1-10 μM). Nefiracetam interacts with PKA and PKC pathways, which may explain a cellular mechanism for the action of cognition-enhancing agents. Lower (submicromolar) concentrations of the nootropic Nefiracetam reduces ACh-evoked currents to 30\% (0.01 μM) and 38\% (0.1 μM) of control after a 10-minute treatment [1]. Nefiracetam administered orally inhibits Ro 5-4864-induced convulsions in EL mice. Nefiracetam also efficiently inhibits Ro 5-4864-induced convulsions in DDY mice at doses higher than 10 mg/kg [2]. Nefiracetam administered daily 1 hour before each training session facilitates the acquisition process of the avoidance response [3].
mepivacaine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
Tryptophan betaine
MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; AOHCBEAZXHZMOR-ZDUSSCGKSA-N_STSL_0038_Tryptophan betaine_0500fmol_180407_S2_LC02_MS02_09; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.
Sophocarpine
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2290 Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1]. Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1]. Sophocarpine is one of the significant alkaloid extracted from the traditional herb medicine Sophora flavescens which has many pharmacological properties such as anti-virus, anti-tumor, anti-inflammatory. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Sophocarpine has been demonstrated to have anti-tumor activity in various cancer cells, including hepatocellular carcinoma, prostate cancer and colorectal cancer[1].
12-METHOXY-4,4-BISNOR-5α-8,11,13-PODOCARPATRIEN-3-OL
ascr#2
A hydroxy ketone ascaroside obtained by formal condensation of the hydroxy group of (5R)-5-hydroxyhexan-2-one with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#3, ascr#4, and ascr#8 in male attraction. Ascr#2 is an ascaroside isolated from Caenorhabditis elegans, potently promotes dauer formation, and also acts as a potent male attractant combined with ascr#3 at low concentration[1].
4,7-DIAZA-SPIRO[2.5]OCTANE-4-CARBOXYLIC ACID BENZYL ESTER
3-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Methyl 4-amino-1-benzyl-1,2,5,6-tetrahydropyridine-3-carboxylate
2,2-(((OXYBIS(PROPANE-2,1-DIYL))BIS(OXY))BIS(METHYLENE))BIS(OXIRANE)
Glyceryl monocaprate
C78276 - Agent Affecting Digestive System or Metabolism
N-Cyclohexyl-4-piperidinecarboxamide hydrochloride
1,3-Dihydroisobenzofuran-5-boronic acid pinacol ester
(2S,5S)-(-)-2-tert-Butyl-3-methyl-5-benzyl-4-imidazolidinone
2-[(4-methoxyphenyl)methyl]-5-propyl-4H-pyrazol-3-one
6-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride
2-(1,1,2,3,3-pentamethyl-2H-inden-5-yl)propan-1-ol
1,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carbonitrile
2-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YL-AMINO)-PROPIONIC ACID
N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,oxolane-2,5-dione
2-Cyclopentyl-1-(4-methoxy-2,3-dimethylphenyl)ethanone
(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)boronic acid
1,6-Diazaspiro[3.4]octane-6-carboxylic acid, phenylmethyl ester
6-(PIPERIDIN-4-YLMETHYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
2-(2-Isopropylphenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane
methyl-2,6,10-trimethyl-2,5,9-cyclododecatriene-1-yl ketone
(2R,5R)-(+)-2-TERT-BUTYL-3-METHYL-5-BENZYL-4-IMIDAZOLIDINONE
2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine,phenol
2-(2-diethylaminoethyl)-1H-isoindole-1,3(2H)-dione
ethyl 6-methyl-2-propan-2-ylimidazo[1,2-a]pyridine-3-carboxylate
2-(4-ISOPROPYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol
DM 235
Sunifiram (DM-235) is an ampakine-like compound with better nootropic activity than piracetam.
3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
tert-butyl 2-(bis(2-aminoethyl)amino)ethylcarbamate
ethyl [2-(boc-amino)ethylamino]acetate hydrochloride
3-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLAMINO)-PROPIONIC ACID
4,4,5,5-Tetramethyl-2-(2,4,6-trimethylphenyl)-1,3,2-dioxaborolane
3-((2-hydroxyethylamino)methyl)-6,8-dimethylquinolin-2(1H)-one
2-(2,3-Dihydrobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
1,5-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carbonitrile
1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANONE
2-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
5-Methoxy-N-methyl-N-(1-methylethyl)-1H-indole-3-ethanamine
3,9-Diazaspiro[5.5]undecane, 3-butyl-, hydrochloride (1:1)
2-(2,3-Dihydrobenzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(4-METHYLPHENYL)DIPHENYLSULFONIUMTRIFLUOROMETHANESULFONATE
trimethyl-(3-methyl-1-trimethylsilyloxybut-1-enoxy)silane
4-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Levomilnacipran
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D002491 - Central Nervous System Agents > D000700 - Analgesics D049990 - Membrane Transport Modulators D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Quinelorane
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate
Disiloxane, 1,3-bis(1,1-dimethylethyl)-1,1,3,3-tetramethyl-
3-[(Dimethylamino)methyl]-4-[methyl(phenyl)amino]furan-2(5H)-one
MG(10:0/0:0/0:0)
MG(10:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(10:0/0:0/0:0) is made up of one decanoyl(R1).
Geroquinol
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
3-(3-Methylbutyryloxy)-4-(trimethylaminio)butanoic acid
3-Carboxylato-2-(2-methylbutyryloxy)-N,N,N-trimethyl-1-propaneaminium
N-[3-(ethoxycarbonylamino)-2,2-dimethylpropyl]carbamic acid ethyl ester
N-(cyclopentylideneamino)-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide
[(2R)-3-carboxy-2-(3-methylbutanoyloxy)propyl]-trimethylazanium
[3-Carboxylato-2-(pentanoyloxy)propyl]trimethylaminium
(5Z)-2,2-dimethyl-5-[2-(4-methylphenyl)hydrazinylidene]tetrahydro-4H-pyran-4-one
(3R)-3,13-dihydroxytridecanoic acid
A dihydroxy monocarboxylic acid that is 13-hydroxytridecanoic acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.
(3R,12R)-3,12-dihydroxytridecanoic acid
An (omega-1)-hydroxy fatty acid that is (12R)-12-hydroxytridecanoic acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.
[(2R)-3-carboxy-2-(2-methylbutanoyloxy)propyl]-trimethylazanium
[(2S)-3-carboxy-2-(2,2-dimethylpropanoyloxy)propyl]-trimethylazanium
[(2S)-3-carboxy-2-pentanoyloxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-pentanoyloxypropyl]-tris(trideuteriomethyl)azanium
(5E,7Z,9Z,11E,13E)-hexadeca-5,7,9,11,13-pentaenoic acid
4-Trimethylsilylmethyl-6-phenyl-5,6-dihydro-2H-pyran
(Z)-3-Methyl-5-oxo-5-phenyl-2-pentenyltrimethylsilane
3-Methylene-5-phenyl-5-trimethylsilyloxy-1-pentene
15-Methoxybicyclo(8.3.2)pentadeca-1(13),10(15),11-trien-14-one
(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoic acid
Parsalmide
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
ascaroside C6
Ascr#2 is an ascaroside isolated from Caenorhabditis elegans, potently promotes dauer formation, and also acts as a potent male attractant combined with ascr#3 at low concentration[1].
Cyclo(L-Phe-L-Val)
Cyclo(L-Phe-L-Val) is a potent inhibitor of enzymes isocitrate lyase (ICL) (IC50=27 μg/mL). cyclo(L-Phe-L-Val) inhibits the gene transcription of ICL in C. albicans under C2-carbon-utilizing conditions[1].
(9s,17s)-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-1-en-6-one
n-(5,7a-dimethyl-1-oxo-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide
8a-methyl-2,3,5-trimethylidene-hexahydro-3ah-naphtho[2,3-b]furan-4a-ol
4-(6-hydroxy-3,7-dimethylocta-1,7-dien-3-yl)phenol
15-methyl-6,17-diazapentacyclo[9.5.1.0¹,⁶.0²,¹⁰.0²,¹³]heptadecane
(1r,9r,10s)-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-en-8-one
2-(3,7-dimethylocta-2,6-dien-1-yl)benzene-1,4-diol
11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one
2-methoxy-4,7-dimethyl-2-(2-methylprop-1-en-1-yl)-3,4-dihydro-1-benzopyran
7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-5-en-4-one
methyl (2e)-5-(4-isopropylphenyl)-2-methylpent-2-enoate
4-[(3s)-6-hydroxy-3,7-dimethylocta-1,7-dien-3-yl]phenol
[(1e,3e,5e)-7-phenylhepta-1,3,5-trien-1-yl]benzene
13,14-dehydrosophoridine
{"Ingredient_id": "HBIN000997","Ingredient_name": "13,14-dehydrosophoridine","Alias": "NA","Ingredient_formula": "C15H22N2O","Ingredient_Smile": "NA","Ingredient_weight": "246.35","OB_score": "65.34313997","CAS_id": "68398-59-4","SymMap_id": "SMIT08175","TCMID_id": "NA","TCMSP_id": "MOL006573","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(+)-2,3-dehydro-10-oxo-α-isosparteine
{"Ingredient_id": "HBIN003955","Ingredient_name": "(+)-2,3-dehydro-10-oxo-\u03b1-isosparteine","Alias": "NA","Ingredient_formula": "C15H22N2O","Ingredient_Smile": "C1CCN2CC3CC(C2C1)C(=O)N4C3CCC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4955","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-methoxyfuranodiene
{"Ingredient_id": "HBIN005911","Ingredient_name": "2-methoxyfuranodiene","Alias": "8alpha-Methoxyfuranodiene","Ingredient_formula": "C16H22O2","Ingredient_Smile": "CC1=CCC2=C(CC(=CC(C1)OC)C)OC=C2C","Ingredient_weight": "246.34 g/mol","OB_score": "53.58213324","CAS_id": "NA","SymMap_id": "SMIT03628","TCMID_id": "NA","TCMSP_id": "MOL001160","TCM_ID_id": "NA","PubChem_id": "6325622","DrugBank_id": "NA"}
2-(phenylmethylene)heptanol
{"Ingredient_id": "HBIN006321","Ingredient_name": "2-(phenylmethylene)heptanol","Alias": "NA","Ingredient_formula": "C16H22O2","Ingredient_Smile": "CCCCCC(=CC1=CC=CC=C1)COC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36549","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(+)-7,11-dehydromatrine,(leontalbinine)
{"Ingredient_id": "HBIN012861","Ingredient_name": "(+)-7,11-dehydromatrine,(leontalbinine)","Alias": "NA","Ingredient_formula": "C15H22N2O","Ingredient_Smile": "NA","Ingredient_weight": "246.35","OB_score": "62.08261476","CAS_id": "16665-57-9","SymMap_id": "SMIT08166","TCMID_id": "NA","TCMSP_id": "MOL006562","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α-methoxyfuranodiene
{"Ingredient_id": "HBIN013635","Ingredient_name": "8\u03b1-methoxyfuranodiene","Alias": "SCHEMBL17793867; AC1O3DN8; (5E,9E)-8-methoxy-3,6,10-trimethyl-4,7,8,11-tetrahydrocyclodeca[b]furan; 2-Methoxyfuranodiene; 8alpha-methoxyfuranodiene; NWLNPDFDTSFGEU-SSQAHJBYSA-N","Ingredient_formula": "C16H22O2","Ingredient_Smile": "CC1=CCC2=C(CC(=CC(C1)OC)C)OC=C2C","Ingredient_weight": "246.34 g/mol","OB_score": "29.72555692","CAS_id": "NA","SymMap_id": "SMIT00445;SMIT19342","TCMID_id": "31541;13925","TCMSP_id": "MOL001169","TCM_ID_id": "NA","PubChem_id": "6325622","DrugBank_id": "NA"}
